1249 related articles for article (PubMed ID: 32321524)
1. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.
Pachetti M; Marini B; Benedetti F; Giudici F; Mauro E; Storici P; Masciovecchio C; Angeletti S; Ciccozzi M; Gallo RC; Zella D; Ippodrino R
J Transl Med; 2020 Apr; 18(1):179. PubMed ID: 32321524
[TBL] [Abstract][Full Text] [Related]
2. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
[TBL] [Abstract][Full Text] [Related]
3. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
[TBL] [Abstract][Full Text] [Related]
4. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.
Islam MR; Hoque MN; Rahman MS; Alam ASMRU; Akther M; Puspo JA; Akter S; Sultana M; Crandall KA; Hossain MA
Sci Rep; 2020 Aug; 10(1):14004. PubMed ID: 32814791
[TBL] [Abstract][Full Text] [Related]
6. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N
J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935
[TBL] [Abstract][Full Text] [Related]
7. Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2.
Pokhrel R; Chapagain P; Siltberg-Liberles J
J Med Microbiol; 2020 Jun; 69(6):864-873. PubMed ID: 32469301
[No Abstract] [Full Text] [Related]
8. Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.
Long SW; Olsen RJ; Christensen PA; Bernard DW; Davis JJ; Shukla M; Nguyen M; Saavedra MO; Yerramilli P; Pruitt L; Subedi S; Kuo HC; Hendrickson H; Eskandari G; Nguyen HAT; Long JH; Kumaraswami M; Goike J; Boutz D; Gollihar J; McLellan JS; Chou CW; Javanmardi K; Finkelstein IJ; Musser JM
mBio; 2020 Oct; 11(6):. PubMed ID: 33127862
[TBL] [Abstract][Full Text] [Related]
9. Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.
Shannon A; Selisko B; Le NT; Huchting J; Touret F; Piorkowski G; Fattorini V; Ferron F; Decroly E; Meier C; Coutard B; Peersen O; Canard B
Nat Commun; 2020 Sep; 11(1):4682. PubMed ID: 32943628
[TBL] [Abstract][Full Text] [Related]
10. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020.
Alm E; Broberg EK; Connor T; Hodcroft EB; Komissarov AB; Maurer-Stroh S; Melidou A; Neher RA; O'Toole Á; Pereyaslov D; ;
Euro Surveill; 2020 Aug; 25(32):. PubMed ID: 32794443
[TBL] [Abstract][Full Text] [Related]
11. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 RNA polymerase as target for antiviral therapy.
Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19.
Chien M; Anderson TK; Jockusch S; Tao C; Li X; Kumar S; Russo JJ; Kirchdoerfer RN; Ju J
J Proteome Res; 2020 Nov; 19(11):4690-4697. PubMed ID: 32692185
[TBL] [Abstract][Full Text] [Related]
14. Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.
Koçhan N; Eskier D; Suner A; Karakülah G; Oktay Y
Infect Genet Evol; 2021 Jul; 91():104796. PubMed ID: 33667722
[TBL] [Abstract][Full Text] [Related]
15. Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.
Weber S; Ramirez C; Doerfler W
Virus Res; 2020 Nov; 289():198170. PubMed ID: 32979477
[TBL] [Abstract][Full Text] [Related]
16. Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.
Zhao Z; Bourne PE
J Proteome Res; 2020 Nov; 19(11):4698-4705. PubMed ID: 32946692
[TBL] [Abstract][Full Text] [Related]
17. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'.
Lavezzo E; Franchin E; Ciavarella C; Cuomo-Dannenburg G; Barzon L; Del Vecchio C; Rossi L; Manganelli R; Loregian A; Navarin N; Abate D; Sciro M; Merigliano S; De Canale E; Vanuzzo MC; Besutti V; Saluzzo F; Onelia F; Pacenti M; Parisi SG; Carretta G; Donato D; Flor L; Cocchio S; Masi G; Sperduti A; Cattarino L; Salvador R; Nicoletti M; Caldart F; Castelli G; Nieddu E; Labella B; Fava L; Drigo M; Gaythorpe KAM; ; Brazzale AR; Toppo S; Trevisan M; Baldo V; Donnelly CA; Ferguson NM; Dorigatti I; Crisanti A;
Nature; 2020 Aug; 584(7821):425-429. PubMed ID: 32604404
[TBL] [Abstract][Full Text] [Related]
18. Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.
Nelson CW; Ardern Z; Goldberg TL; Meng C; Kuo CH; Ludwig C; Kolokotronis SO; Wei X
Elife; 2020 Oct; 9():. PubMed ID: 33001029
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic.
Zhang W; Govindavari JP; Davis BD; Chen SS; Kim JT; Song J; Lopategui J; Plummer JT; Vail E
JAMA Netw Open; 2020 Oct; 3(10):e2024191. PubMed ID: 33026453
[TBL] [Abstract][Full Text] [Related]
20. Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach.
Parvez MSA; Karim MA; Hasan M; Jaman J; Karim Z; Tahsin T; Hasan MN; Hosen MJ
Int J Biol Macromol; 2020 Nov; 163():1787-1797. PubMed ID: 32950529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
